U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    FABP4 fatty acid binding protein 4 [ Homo sapiens (human) ]

    Gene ID: 2167, updated on 17-Sep-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    FABP4 concentrations should be taken into consideration as an early marker of kidney damage in patients with type 2 diabetes.

    Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria.
    Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M, Masana L.

    01/21/2010
    thiazolidinedione increases FABP4 plasma concentrations in diabetic patients, reflecting PPARgamma activation

    Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients.
    Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M, Masana L.

    01/21/2010
    Hypoxia enhances the expression of FABP4 in term human trophoblasts, suggesting that fatty acid binding proteins support fat accumulation in the hypoxic placenta.

    Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts.
    Biron-Shental T, Schaiff WT, Ratajczak CK, Bildirici I, Nelson DM, Sadovsky Y., Free PMC Article

    01/21/2010
    These data indicate for the first time that human macrophage aP2 promoter is a direct target for the regulation by LXR/RXR heterodimers.

    Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
    Liu QY, Quinet E, Nambi P.

    01/21/2010
    observations suggest that oxLDL-mediated increase in gene expression accelerate cholesterol ester accumulation, and that this is an important component of the genetic program regulating conversion of macrophages to foam cells

    The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages.
    Fu Y, Luo N, Lopes-Virella MF, Garvey WT.

    01/21/2010
    intra-pair correlations revealed that FATP4 expression was signifcantly up-regulated in acquired obesity.

    Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance.
    Gertow K, Pietiläinen KH, Yki-Järvinen H, Kaprio J, Rissanen A, Eriksson P, Hamsten A, Fisher RM.

    01/21/2010
    Data demonstrate a significant genetic variation in humans that results in decreased adipose tissue aP2 expression due to alteration of the CAAT box/enhancer-binding protein binding and reduced transcriptional activity of the aP2 promoter.

    A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.
    Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB, Hotamisligil GS., Free PMC Article

    01/21/2010
    the metallothionein genes, adipophilin (ADFP), CD36, adipocyte fatty acid binding protein (FABP4), ATP binding cassette protein A1 (ABCA1), and liver X receptor (LXR[alpha]) all emerged as strongly positively correlated with PPAR[gamma] expression.

    Predominance of a proinflammatory phenotype in monocyte-derived macrophages from subjects with low plasma HDL-cholesterol.
    Sarov-Blat L, Kiss RS, Haidar B, Kavaslar N, Jaye M, Bertiaux M, Steplewski K, Hurle MR, Sprecher D, McPherson R, Marcel YL.

    01/21/2010
    ALBP gene expression accelerates cholesterol and triglyceride accumulation in macrophage foam cells and affects some key gene expression for lipid metabolism.

    Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages.
    Fu Y, Luo L, Luo N, Garvey WT.

    01/21/2010
    genetic variability at the FABP4 locus has been shown to be associated with plasma lipid levels, type 2 diabetes, and coronary heart disease risk

    Identification of a functional polymorphism at the adipose fatty acid binding protein gene (FABP4) and demonstration of its association with cardiovascular disease: a path to follow.
    Ordovas JM.

    01/21/2010
    a pre-lipolysis complex containing at least AFABP and HSL exists

    Physical association between the adipocyte fatty acid-binding protein and hormone-sensitive lipase: a fluorescence resonance energy transfer analysis.
    Smith AJ, Sanders MA, Thompson BR, Londos C, Kraemer FB, Bernlohr DA.

    01/21/2010
    Loss of expression of A-FABP is associated with progression of bladder carcinoma.

    Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
    Ohlsson G, Moreira JM, Gromov P, Sauter G, Celis JE.

    01/21/2010
    Expression occurs not only in mature adipocytes, but has a wider embryonic expression pattern than previously appreciated.

    Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development.
    Urs S, Harrington A, Liaw L, Small D.

    01/21/2010
    Changes in DNA methylation at adipogenic promoters during cellular aging.

    Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence.
    Noer A, Boquest AC, Collas P., Free PMC Article

    01/21/2010
    fatty acid binding protein 4 and PPARgamma work together to influence a biologic pathway affecting insulin sensitivity and body composition

    Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males.
    Damcott CM, Moffett SP, Feingold E, Barmada MM, Marshall JA, Hamman RF, Ferrell RE.

    01/21/2010
    FABP4 protein is expressed within the skeletal muscle fibers & FABP4 mRNA & protein are more abundant in the endurance trained subjects.[fatty acid binding protein 4]

    Fatty acid binding protein 4 in human skeletal muscle.
    Fischer H, Gustafsson T, Sundberg CJ, Norrbom J, Ekman M, Johansson O, Jansson E.

    01/21/2010
    firstprevious page of 12 nextlast